These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2895289)

  • 1. Interferon-alpha for idiopathic myelofibrosis.
    Lancet; 1988 Apr; 1(8588):765-6. PubMed ID: 2895289
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-alpha-2 in the treatment of idiopathic myelofibrosis.
    Seewann HL; Gastl G; Lang A; Abbrederis K; Thaler J; Flener R; Huber C
    Blut; 1988 Apr; 56(4):161-3. PubMed ID: 3355903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-interferon in primary idiopathic myelofibrosis.
    Wickramasinghe SN; Peart S; Gill DS
    Lancet; 1987 Dec; 2(8574):1524-5. PubMed ID: 2892080
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia.
    Parmeggiani L; Ferrant A; Rodhain J; Michaux JL; Sokal G
    Eur J Haematol; 1987 Sep; 39(3):228-32. PubMed ID: 3678474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of splenomegaly and anemia by VP therapy in idiopathic myelofibrosis complicated with acromegaly: a case report].
    Imai Y; Akiyama N; Hanazono Y; Inamori K; Mitani K; Hirai H; Nagai R; Yazaki Y
    Rinsho Ketsueki; 1995 Oct; 36(10):1233-6. PubMed ID: 8531337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-interferon in the treatment of idiopathic myelofibrosis.
    List AF; Doll DC
    Br J Haematol; 1992 Apr; 80(4):566-7. PubMed ID: 1581246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current therapeutic possibilities in idiopathic myelofibrosis. Observations on 47 cases].
    Perugini S; Ascari E; Fontana G
    Clin Ter; 1968 Apr; 45(1):21-60. PubMed ID: 4897957
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant interferon-α may retard progression of early primary myelofibrosis: a preliminary report.
    Silver RT; Vandris K; Goldman JJ
    Blood; 2011 Jun; 117(24):6669-72. PubMed ID: 21518929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of huge splenomegaly under alpha interferon treatment of hairy cell leukemia.
    Afeltra A; Caccavo D; Siena MM; Bonomo L
    Haematologica; 1988; 73(1):67-70. PubMed ID: 3131207
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia.
    Barosi G; Liberato LN; Costa A; Buratti A; Di Dio F; Salvatore S; Ascari E
    Eur J Haematol Suppl; 1990; 52():12-4. PubMed ID: 2279538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon in myelofibrosis.
    Hasselbalch H
    Lancet; 1988 Feb; 1(8581):355. PubMed ID: 2893159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of myelofibrosis--where next?
    Qureshi M; Harrison C
    Expert Opin Pharmacother; 2011 Jul; 12(10):1453-5. PubMed ID: 21651445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Onset of polycythemia in idiopathic myelofibrosis. Description of a clinical case and review of the literature].
    Pagano L; Teofili L; Marra R; Storti S; Rabbitti C; Leone G; Bizzi B
    Minerva Med; 1988 Jan; 79(1):51-4. PubMed ID: 3277085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H; Clemmensen I
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of myelofibrosis with alfa-interferon.
    McCarthy D; Clark J; Giles F
    Br J Haematol; 1991 Aug; 78(4):590-1. PubMed ID: 1911363
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtotal splenectomy in myelofibrosis.
    Morgenstern L; Kahn FH; Weinstein IM
    Surgery; 1966 Aug; 60(2):336-9. PubMed ID: 5915462
    [No Abstract]   [Full Text] [Related]  

  • 19. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued Role of Splenectomy in the Management of Patients With Myelofibrosis.
    Aruch D; Schwartz M; Mascarenhas J; Kremyanskaya M; Newsom C; Hoffman R
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):e133-e137. PubMed ID: 27373368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.